287 results
Page 8 of 15
8-K
EX-99.1
zo5ahma2i
21 Aug 20
VBI Vaccines Announces Multiple Phase 3 Sci-B-Vac® Abstracts Accepted for Oral and Poster Presentations at EASL 2020
11:13am
8-K
EX-99.1
g7ihw9hhhv1env
5 Aug 20
VBI Vaccines Awarded Up to CAD$56 Million Contribution from Canadian Government to Accelerate Coronavirus Vaccine Development
9:00am
8-K
EX-99.1
gvip05v
3 Aug 20
VBI Vaccines Announces Second Quarter 2020 Financial Results and Provides Corporate Update
9:10am
S-3ASR
EX-1.2
yi5agu8egq
31 Jul 20
Automatic shelf registration
4:58pm
8-K
EX-99.2
vb5a7cv7otg29kc2ps
22 Jun 20
Regulation FD Disclosure
8:46am
8-K
EX-99.1
5j2jru3e amt8o4zv
17 Jun 20
VBI Vaccines to Present at Upcoming Investor Conferences
8:54am
8-K
EX-99.1
0731eh 59
27 May 20
VBI Vaccines Secures $50 Million Debt Financing From K2 HealthVentures
5:15pm
8-K
EX-10.1
tvkb3pu8jtbrz0wzt
27 May 20
VBI Vaccines Secures $50 Million Debt Financing From K2 HealthVentures
5:15pm
8-K
EX-99.1
cnr5c1396igyne6lk0cv
15 May 20
VBI Vaccines Announces Upcoming Poster Presentation of Phase 1/2a data of VBI-1901 in Recurrent GBM Patients at AACR Virtual Annual Meeting
12:39pm
8-K
EX-99.1
7b84z 9msv3xlu
6 May 20
Results of Operations and Financial Condition
8:35am
8-K
EX-99.1
amx2cr oobeaod1bzc
27 Apr 20
VBI Vaccines Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
8:52am
8-K
EX-4.1
4b58rrt7um3eqth2j4
27 Apr 20
VBI Vaccines Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
8:52am
8-K
EX-1.1
y21i22o2
24 Apr 20
VBI Vaccines Announces Proposed Public Offering of Common Shares
6:16am
8-K
EX-99.2
irh smmunf
24 Apr 20
VBI Vaccines Announces Proposed Public Offering of Common Shares
6:16am
8-K
EX-99.1
1kxewq6c5 nv9wx
24 Apr 20
VBI Vaccines Announces Proposed Public Offering of Common Shares
6:16am
424B5
5h7j8d7bqmh
21 Apr 20
Prospectus supplement for primary offering
4:18pm
8-K
EX-99.1
pugs q3lgm
31 Mar 20
VBI Vaccines Announces Collaboration with the National Research Council of
8:14am